OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-35 Cr | ₹-55 Cr | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹-35 Cr |
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-9.59 Cr |
| Mar2023 | ₹-7.89 Cr |
| Mar2022 | ₹1.50 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹-35 Cr | Negative | |
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-9.59 Cr | Negative | |
| Mar2023 | ₹-7.89 Cr | Negative | |
| Mar2022 | ₹1.50 Cr | - | |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹177.6 Cr | 3% | -4.4% | -30.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3% |
-4.4% |
-30.1% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses